Emerging Role of GLP-1 Receptor Agonists for the Treatment of MASH
Abstract: Emerging as a major global health concern, metabolic dysfunction-associated steatohepatitis (MASH) is closely linked to obesity, type 2 diabetes,...
Continue Reading
Abstract: Emerging as a major global health concern, metabolic dysfunction-associated steatohepatitis (MASH) is closely linked to obesity, type 2 diabetes,...
Continue Reading
Introduction In recognition of International Women’s Day, we spotlight women’s health—a continuously evolving global healthcare issue. The year 2025 marks...
Continue Reading
Introduction: Women spend about one-third of their lives in menopause or post-menopause, a period that marks the gradual decline of...
Continue Reading
Introduction: Fibrosis is a pathological process characterized by the excessive deposition of extracellular matrix (ECM) within an organ, leading to...
Continue Reading
Introduction: OncoWuXi Express will continue to keep you informed about updates to our online tumor model database (OncoWuXi Database), as...
Continue Reading
Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory condition that is mediated by genetic, immune, and environmental factors. Due...
Continue Reading
Introduction: Molecular glues (MGs) are a class of small molecules that alter the surface properties of proteins to strengthen or...
Continue Reading
OncoWuXi Express will continue to keep you informed about updates to our online tumor model database (OncoWuXi Database), as well...
Continue Reading
Glucagon‐like peptide‐1 (GLP-1) receptor agonists have emerged as promising therapeutic options for addressing type‐2 diabetes, obesity, and related conditions. However,...
Continue Reading